FTO and esophageal squamous cell carcinoma: Cui et al. found that the increase of FTO in esophageal squamous cell carcinoma (ESCC) inhibited the decay of LINC00022 through m6A reader YTHDF2, thus, promoting cell cycle progression and proliferation (Cui et al., 2021).